miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells.
miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells.
复制标题
DOI:
10.1002/stem.101
复制
发表时间:
2009-08
期刊:
影响因子:
5.2
通讯作者:
Sarkar, Fazlul H.
中科院分区:
文献类型:
--
作者:
Kong, Dejuan;Li, Yiwei;Wang, Zhiwei;Banerjee, Sanjeev;Ahmad, Aamir;Kim, Hyeong-Reh Choi;Sarkar, Fazlul H.
关键词:
MicroRNAs have been implicated in tumor progression. Recent studies have shown that miR-200 family regulates Epithelial-Mesenchymal Transition (EMT) by targeting zinc-finger E-box binding homeobox 1 (ZEB1) and ZEB2. Emerging evidence from our laboratory and others suggest that the processes of EMT can be triggered by various growth factors such as Transforming Growth Factor-beta (TGF-β) and Platelet-Derived Growth Factor-D (PDGF-D). Moreover, we have recently reported that over-expression of PDGF-D in prostate cancer cells (PC3 PDGF-D cells) leads to the acquisition of EMT phenotype, and this model offers an opportunity for investigating the molecular interplay between PDGF-D signaling and EMT. Here we report, for the first time, significant down-regulation of miR-200 family in PC3 PDGF-D cells as well as in PC3 cells exposed to purified active PDGF-D protein, resulting in the up-regulation of ZEB1, ZEB2 and snail2 expression. Interestingly, re-expression of miR-200b in PC3 PDGF-D cells led to the reversal of EMT phenotype, which was associated with the down-regulation of ZEB1, ZEB2 and snail2 expression and these results were consistent with increased gene expressions of epithelial markers. Moreover, transfection of PC3 PDGF-D cells with miR-200b inhibited cell migration and invasion with concomitant repression of cell adhesion to culture surface and cell detachment. From these results, we conclude that PDGF-D induced acquisition of EMT phenotype of PC3 cells is in part due to repression of miR-200 and that any novel strategies by which miR-200 could be up-regulated would become a promising approach for the treatment of invasive prostate cancer.
登录
查看更多内容
影响因子:
15.8
作者:
Lee TH;Seng S;Sekine M;Hinton C;Fu Y;Avraham HK;Avraham S
通讯作者:
Avraham S
影响因子:
11.2
作者:
Bracken, Cameron P.;Gregory, Philip A.;Goodall, Gregory J.
通讯作者:
Goodall, Gregory J.
影响因子:
8
作者:
Bindels, S.;Mestdagt, M.;Gilles, C.
通讯作者:
Gilles, C.
影响因子:
11.2
作者:
Graham, Tisheeka R.;Zhau, Haiyen E.;O'Regan, Ruth M.
通讯作者:
O'Regan, Ruth M.
影响因子:
5.2
作者:
Kong, Dejuan;Wang, Zhiwei;Sarkar, Fazlul H.
通讯作者:
Sarkar, Fazlul H.